Determinants of the interindividual variability in response to antiplatelet drugs
- 1 August 2005
- journal article
- review article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 3 (8) , 1597-1602
- https://doi.org/10.1111/j.1538-7836.2005.01380.x
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjectsJournal of the American College of Cardiology, 2005
- Clopidogrel Resistance Is Associated With Increased Risk of Recurrent Atherothrombotic Events in Patients With Acute Myocardial InfarctionCirculation, 2004
- Contribution of Hepatic Cytochrome P450 3A4 Metabolic Activity to the Phenomenon of Clopidogrel ResistanceCirculation, 2004
- Adenosine Diphosphate–Induced Platelet Aggregation Is Associated With
P2Y
12
Gene Sequence Variations in Healthy SubjectsCirculation, 2003
- Clopidogrel for Coronary StentingCirculation, 2003
- Common Promoter Variant in Cyclooxygenase-2 Represses Gene ExpressionArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Increased platelet reactivity in patients given orbofiban after an acute coronary syndrome: an OPUS-TIMI 16 substudyThe American Journal of Cardiology, 2000
- DipyridamoleNew England Journal of Medicine, 1987
- Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease.Circulation, 1983
- Selective Cumulative Inhibition of Platelet Thromboxane Production by Low-dose Aspirin in Healthy SubjectsJournal of Clinical Investigation, 1982